Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group

Reporter: J Taylor Whaley, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de junio del 2013

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Human Papillomavirus Load Linked to Cervical Cytology

Nov 26, 2015

Linked to cytology severity in women who do not develop cervical intraepithelial neoplasia

Psychosocial Phone Counseling Aids Cervical Cancer Survivors

Mar 12, 2015

Improvements in depression; lasting improvement in gynecologic and cancer-specific concerns

Guidelines Stretch Interval for Cervical Cancer Screening

Oct 24, 2012

Cytology testing recommended every three to five years; co-testing for HPV starting at age 30